One of Japan's most celebrated singers harnessed Dreamtonics' vocal processing to create a new voice which transcends time ...

Accurate time synchronization is the backbone of many critical technologies, from navigation and communication to cutting-edge research in physics. However, conventional methods like pseudocode-based ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

Regeneron stock jumped Tuesday after the biotech giant topped Wall Street's December-quarter calls on the back of its cancer drug Libtayo.

Sales of Eylea, which the company co-developed with Bayer (DE:BAYA), rose 2% to $1.495 billion. Sales of the higher-dose, longer-lasting formulation Eylea HD rose 148% to $305 million in the U.S., ...

MAIA Biotechnology, Inc., ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced positive updated data from its THIO-101 ...

Precision medicine is revolutionizing healthcare, and these genomic stocks are leading the way. Therefore, as this sector ...

With respect to climate change, 2024 was in many ways similar to 2023: Manifestations of a changed climate continued to be felt increasingly across the world, even as the clean-energy transition ...

Despite recent development efforts, progress is still slow and cannot be relied upon to revive the country. Unless the mindset shifts to “Time is more precious than money”, true progress cannot be ...

All films will run a few minutes shorter than the allotted air time — leaving plenty of room for a message from the sponsor. Contact us at [email protected] ...

but with time, it will be in a better position to pay back that debt and get its multiple to re-rate. Debt, debt, debt. There's a lot of debt that Progress has to chop back. That will get in the ...